In its third-quarter results update, the Tuebingen, Germany-based biotech said it had been informed by GSK in early October that it would be terminating their partnership announced in February ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted R1 model knocked tech stocks, sending the Nikkei ( ^N225) in Japan 0.9% ...

The €150 million collaboration between UK pharma GSK and Germany’s CureVac builds on their existing relationship and will jointly develop next generation mRNA vaccines. It will attempt to ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted ...

European stocks closed broadly higher on Tuesday, recovering fairly well after losing ground in the previous session due to a ...

The biggest risers on the FTSE 100 were British American Tobacco, up 142p to 3,150p, ConvaTec, up 9p to 248.4p, GSK, up 45.5p ...

European stocks closed lower on Monday, with several markets falling after several days of gains, due to a sell-off in the tech ...

GSK (GSK), St James’s Place (STJ), Oxford Nanopore Technologies ... fell 19.1 per cent on the back of softer trading in Germany and France. The Americas, Asia Pacific and UK also reported double-digit ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...